Quarfloxin in Patients With Low to Intermediate Grade Neuroendocrine Carcinoma

Clinical trial NCT00780663 · COMPLETED

Trial details

NCT number: NCT00780663
Sponsor: Cylene Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumors Carcinoid Tumor

Start date: 2008-10-01
Primary completion: 2010-03-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.